Stay updated on Tucatinib & Trastuzumab in HER2+ Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Tucatinib & Trastuzumab in HER2+ Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tucatinib & Trastuzumab in HER2+ Solid Tumors Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page’s revision label in the footer changed from v3.6.4 to v3.6.5, reflecting a new build of the site. This update appears to affect only metadata and not study content or user tasks.
    Difference
    0.0%
    Check dated 2026-08-11T16:22:11.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    A new Revision: v3.6.4 entry was added to the study record history. The previous Revision: v3.6.3 entry was removed.
    Difference
    0.0%
    Check dated 2026-07-28T05:17:35.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    40 days ago
    Change Detected
    Summary
    The footer now shows Revision: v3.6.3 instead of v3.6.2, signaling a new site release. There are no changes to the study records or page navigation reflected by this update.
    Difference
    0.0%
    Check dated 2026-07-06T15:50:13.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The revision badge on the page updated from v3.6.0 to v3.6.2, signaling a platform release. No study data or navigation elements appear to be changed.
    Difference
    0.0%
    Check dated 2026-06-29T08:54:03.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    The recruitment status changed to not actively recruiting participants, and the record history shows a new software revision (v3.6.0) with the prior revision (v3.5.5) removed.
    Difference
    0.2%
    Check dated 2026-06-15T05:35:48.000Z thumbnail image
  8. Check
    69 days ago
    Change Detected
    Summary
    The history now shows Revision: v3.5.5 as the latest entry, replacing the previous Revision: v3.5.4.
    Difference
    0.0%
    Check dated 2026-06-08T03:48:30.000Z thumbnail image

Stay in the know with updates to Tucatinib & Trastuzumab in HER2+ Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tucatinib & Trastuzumab in HER2+ Solid Tumors Clinical Trial page.